drugset / Trial / NCT06616883

Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers

NCT06616883 ↗

Phase 1 Not yet recruiting 44 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

Pharmacokinetics and Safety Profiles After Administration of DA-5221\_01 and Co-administration of 5221\_01-R1 and DA-5221\_01-R2 in Healthy Adult Volunteers

Timeline

Start
2024-09-30
Primary completion
2024-11-14
Completion
2024-11-18

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-5221_01 Unknown — —
Subject DA-5221_01-R1 Unknown — —
Subject DA-5221_01-R2 Unknown — —

Indications

No indication recorded.